ClinicalTrials.gov
public full text
Public Domain
A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin
The purpose of this Real-World Evidence study is to generate real world data from participants with cough associated with the common cold, evaluating the effects in two arms with commercially available cough syrups on health-related quality of life (QoL). Arm 1 includes one cough syrup (which can be used day or night) and Arm 2 includes the daytime cough syrup and a nighttime cough syrup.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF#800651
- Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)#1058276
- Nutramax Joint Health Formulation Biochemical Response Study#824962
- Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough#883040
- Open-label Study of the Effects of Montelukast in Patients With Chronic Cough#1308553
Record · ID 1337306
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive